Results 31 to 40 of about 2,755,321 (217)

Isoniazid/acetylisoniazid urine concentrations: markers of adherence to isoniazid preventive therapy in children [PDF]

The International Journal of Tuberculosis and Lung Disease, 2014
The Arkansas colorimetric method monitors adherence to isoniazid (INH) by the detection of INH metabolites in urine. Urine samples 4 h after INH administration in 31 human immunodeficiency virus infected children receiving daily or thrice weekly INH preventive therapy were Arkansas test-positive for 29/31 (94%), while acetylisoniazid (AcINH) was ...
V, Amlabu, C, Mulligan, N, Jele, A, Evans, D, Gray, H J, Zar, H, McIlleron, P, Smith   +7 more
openaire   +2 more sources

Safety of long-term isoniazid preventive therapy in children with HIV [PDF]

, 2014
Includes bibliographical references.Tuberculosis (TB) and HIV co-infection is association with significant morbidity and mortality, especially in young children.
Le Roux, Stanzi Maria
core   +1 more source

Isoniazid‐induced pellagra in a patient with Crohn's disease

Clinical Case Reports, 2020
Isoniazid preventive therapy in malnourished patients with Crohn's disease has a potential of inducing pellagra but still a very rare situation. No cases of isoniazid‐induced pellagra in patients with Crohn's disease were reported in the literature ...
Hela Kchir, Haythem Yacoub, Hajer Hassine, Nadia Maamouri   +3 more
doaj   +1 more source

Effect of Isoniazid Preventive Therapy on the Incidence of Tuberculosis among Seropositive Children Attending HIV/AIDS Care in Two General Hospitals, Northwest Ethiopia, 2021

Journal of Tropical Medicine, 2021
The human immune deficiency virus (HIV) is the strongest risk factor for the incidence of tuberculosis (TB) by way of reactivation of latent or new infection.
Fassikaw Kebede, Birhanu Kebede, Tsehay Kebede, Melaku Agmasu   +3 more
doaj   +1 more source

Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. [PDF]

, 2011
BACKGROUND: The World Health Organization recommends the screening of all people living with HIV for tuberculosis (TB) disease, followed by TB treatment, or isoniazid preventive therapy (IPT) when TB is excluded.
Grant, Alison D, Kevin P. Cain, Charles M Heilig, Kimerling, Michael, Varma, Jay K, Kimerling Michael, Lawn, Stephen D, Elizabeth L Corbett, Getahun, Haileyesus, Granich, Reuben, Maartens Gary, Gavin J. Churchyard, Varma Jay K., Maartens, Gary, Wanitchaya Kittikraisak, Alison D Grant, Kittikraisak Wanitchaya, Lawn Stephen D., Elizabeth L. Corbett, Corbett, Elizabeth L, Helen Ayles, Stephen D. Lawn, Kevin P Cain, Corbett Elizabeth L., Date Anand A., Kittikraisak, Wanitchaya, Charles M. Heilig, Jay K. Varma, Wood, Robin, Michael Kimerling, Cain, Kevin P, Churchyard Gavin J., Anand A. Date, Getahun Haileyesus, Ayles, Helen, Shah Sarita, Jay K Varma, Haileyesus Getahun, Ayles Helen, Reuben Granich, Churchyard, Gavin J, Grant Alison D., Robin Wood, Stephen D Lawn, Date, Anand A, Heilig, Charles M, Heilig Charles M., Anand A Date, Gary Maartens, Granich Reuben, Shah, Sarita, Alison D. Grant, Wood Robin, Gavin J Churchyard, Sarita Shah, Cain Kevin P.   +55 more
core   +1 more source

Isoniazid Preventive Therapy Added to ART to Prevent TB: An Individual Participant Data Meta-Analysis [PDF]

, 2020
Background: Isoniazid preventive therapy prevents active tuberculosis in people with HIV, but previous studies have found no evidence of benefit in people with HIV who had a negative tuberculin skin test, and a non-significant effect on mortality.
Anglaret, Xavier, Walker, A Sarah, Ford, Nathan, Golub, Jonathan E, FORD, N., Gabillard, Delphine, Ross, Jennifer M, Shapiro, Adrienne, Boulle, A, Barnabas, Ruanne V, Badje, A, Maartens, Gary, BOULLE, A., Anglaret, X, Rangaka, M, Barnabas, Ruanne, Thomas, Katherine K, THOMAS, K. K., Ross, JM, WALKER, A. S., Williams, Brian G, MAARTENS, G., Walker, Ann Sarah, Barnabas, R, Walker, A, BARNABAS, R. V., WILKINSON, R. J., Thomas, Katherine, GOLUB, J. E., Rangaka, Molebogeng, SHAPIRO, A. E., Shapiro, A, Ford, N, Wilkinson, Robert J, Walker, Sarah, Maartens, G, Eholie, Serge, Badje, Anani, EHOLIE, Serge P., Williams, BG, Eholie, S, Ross, Jennifer, Shapiro, Adrienne E, Gabillard, D, RANGAKA, M. X., Rangaka, Molebogeng X, Williams, Brian, Wilkinson, RJ, Golub, J, Boulle, Andrew, BADJE, Anani Dodzi, Barnabas, Ruane, Golub, Jonathan, Thomas, K, WILLIAMS, B. G., ROSS, J. M.   +55 more
core   +1 more source

A Trial of Mass Isoniazid Preventive Therapy for Tuberculosis Control [PDF]

New England Journal of Medicine, 2014
Tuberculosis is epidemic among workers in South African gold mines. We evaluated an intervention to interrupt tuberculosis transmission by means of mass screening that was linked to treatment for active disease or latent infection.In a cluster-randomized study, we designated 15 clusters with 78,744 miners as either intervention clusters (40,981 miners ...
Gavin J, Churchyard, Katherine L, Fielding, James J, Lewis, Leonie, Coetzee, Elizabeth L, Corbett, Peter, Godfrey-Faussett, Richard J, Hayes, Richard E, Chaisson, Alison D, Grant   +8 more
openaire   +7 more sources

Improving coverage and completion rate of isoniazid preventive therapy among eligible HIV patients using quality improvement approaches: a case study of State Hospital, Ijebu Ode, Ogun State, Nigeria

The Pan African Medical Journal, 2019
Introduction: tuberculosis (TB) is a major killer of people living with HIV. One key strategy to reduce the incidence of tuberculosis in HIV patients is the use of Isoniazid Preventive Therapy (IPT). However, coverage of IPT among eligible HIV clients is
Olabanjo Okunlola Ogunsola, Oluseye Ajayi, Omobola Ojo, Oluwatomisin Adeyeye, Yewande Akinro, Oluwabunmi Oke, Adefolake Adebare Adurogbola, Olalere Olajide   +7 more
doaj   +1 more source

Risk-benefit analysis of tuberculosis infection testing for household contact management in high-burden countries: a mathematical modelling study

The Lancet Global Health, 2020
Summary: Background: Preventive therapy for tuberculosis reduces the risk of disease in people who have been infected but who are not sick. Countries with a high burden of tuberculosis that are expanding preventive therapy use must decide how ...
Courtney M Yuen, PhD, James A Seddon, PhD, Salmaan Keshavjee, ProfMD, Peter J Dodd, PhD   +3 more
doaj   +1 more source

Coverage of isoniazid preventive therapy among people living with HIV; A retrospective cohort study in Tanzania (2012-2016)

International Journal of Infectious Diseases, 2021
Background: Isoniazid Preventive Therapy (IPT) is a proven public health tool to reduce Tuberculosis (TB) among people living with HIV. However, its implementation in most countries is suboptimal.
Werner Maokola, Bernard Ngowi, Lovetti Lawson, Masanja Robert, Michael Mahande, Jim Todd, Sia Msuya   +6 more
doaj   +1 more source